5 Reasons to Buy Keryx Pharmaceuticals

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 4 August, 2015 by The TZ Newswire Staff

5 Reasons to Buy Keryx Pharmaceuticals

Small cap biotech Keryx Pharmaceuticals’ newly launched drug Auryxia looks like a clinical winner, yet the stock has been hit hard recently. Here are 5 reasons why Keryx could be a buy today.

See also
- Next Article The History of Banking in One Chart
- Previous Article 3-D printing helps the medicine go down
Editorial Calender

August 2015

M T W T F S S

1 2

3 4 5 6 7 8 9

10 11 12 13 14 15 16

17 18 19 20 21 22 23

24 25 26 27 28 29 30

31

« Jul Sep »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 4 August, 2015 by The TZ Newswire Staff

5 Reasons to Buy Keryx Pharmaceuticals

See also

Editorial Calender

Recent Tags